Monte Rosa Therapeutics Inc (GLUE) — Financial Flexibility Index
Monte Rosa Therapeutics Inc (GLUE) has a Financial Flexibility Index of -0.35x as of June 2026. Free cash flow of $-74.89 Million (operating CF $-81.48 Million minus capex $6.59 Million) represents 0% of total liabilities ($211.03 Million). Check GLUE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monte Rosa Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Monte Rosa Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Monte Rosa Therapeutics Inc cash conversion from operations.
Annual Financial Flexibility Index for Monte Rosa Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Monte Rosa Therapeutics Inc. Explore Monte Rosa Therapeutics Inc (GLUE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | $-18.10 Million | $-22.80 Million | $215.60 Million | ▼ -139.4% |
| 2024 | 0.21x | $45.98 Million | $42.00 Million | $215.80 Million | ▲ +207.1% |
| 2023 | -0.20x | $-24.76 Million | $-43.80 Million | $124.50 Million | ▲ +82.3% |
| 2022 | -1.12x | $-79.56 Million | $-92.47 Million | $70.98 Million | ▲ +57.5% |
| 2021 | -2.64x | $-49.63 Million | $-59.36 Million | $18.81 Million | ▼ -1216.1% |
| 2020 | -0.20x | $-19.66 Million | $-23.05 Million | $98.11 Million | ▲ +2.7% |
| 2019 | -0.21x | $-4.79 Million | $-6.17 Million | $23.24 Million | — |